Angitia Biopharmaceuticals is a multinational research and development enterprise focusing on discovery and development of new drugs for grievous bone, muscle, and joint diseases.
Lead the design and execution of innovative antibody discovery projects, covering the full workflow from immunization to candidate selection. Drive conventional and next-generation single B cell-based antibody discovery workflows, including high-throughput pipelines and data analysis.
Angitia Biopharmaceuticals is a multinational research and development enterprise focusing on discovery and development of new drugs for grievous bone, muscle, and joint diseases.
Stjude